BREAKING: Health care bill pulled President Trump and Speaker Paul Ryan have pulled the GOP’s plan to repeal and replace Obamacare.

Translate to Spanish or other 102 languages!

Summary: This afternoon, Speaker Ryan joined Dana Perino on Fox News’s America’s News Headquarters to offer a simple reminder: Failing to pass the American Health Care Act means the Obamacare collapse continues—and good people will get hurt along the way.

Mega Doctor News

- Advertisement -

Not enough votes —

BREAKING: Health care bill pulled

President Trump and Speaker Paul Ryan have pulled the GOP’s plan to repeal and replace Obamacare.

Remember: Obamacare is collapsing:

“Obamacare is a collapsing law—double-digit premiums this year, a projection of even higher premium increases next year. Basically forced insurance monopolies—five states, one plan left; a thousand counties, one insurer left. Insurers are pulling out of the marketplace. So the thing’s collapsing. So people are trying to compare what we’re doing with a law that is quickly collapsing, and it’s really kind of a faulty comparison. And what we have long said is we need to repeal and replace this law with patient-centered health care to give people choices. Let people buy what they want to buy, not what the government forces them to buy. I know people on the Left don’t like that, but . . . that’s what we think will save the American health care system—having a patient-centered system with choice and competition.”

Doing nothing is not a choice:

- Advertisement -

“Doing nothing means the collapse occurs and good people get hurt. Doing nothing means skyrocketing premiums coming up in 2017 and 2018. Doing nothing means more insurance companies pull out and people have nothing. So we just believe we have a moral obligation and a duty now that we’re the governing party to step in front of that collapse—and, by the way, replace it with good reforms that work. These reforms, whenever tested, have worked. So we really believe we’re onto something good here.”

That’s why it’s go time:

“We are in the fourth quarter of the House passing this bill, which is the fourth committee. Now that we’re getting to the fourth committee of a four committee process, that’s when a lot of negotiations really intensify, near the end of the process. And that’s what this is—this is called legislating. . . . What’s important for us is, we have to broker compromises to make sure that we draft legislation that can actually pass. . . .We know we’ll feel good at the end of the day here because members promised that we would repeal and replace this disastrous and collapsing law. And that is what we are intent on doing.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Robotic Surgery Program Expanded at STHS McAllen

From smaller incisions and less pain to shorter hospital stays and faster recovery times, robotic-assisted surgery is changing the way patients experience surgical care.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

Highway Crash Leads to Unexpected STC Connection

What began as a flat tire on the side of a highway turned into a frightening collision and an unexpected encounter for South Texas College faculty member Jesus Amaya, when the paramedic who responded to the scene turned out to be one of STC’s graduates.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -